Thursday, April 3, 2008

[StemCells] Genes Cancers and Stem cells

The same gene in the same cancer can play a completely different role

The same gene in the same cancer can play a completely different role
by Jennifer Davis
Published 03/31/2008 in Brain Cancer | Unrated


Perhaps the only positive spin one can put on the brain cancer
glioblastoma is that it's relatively uncommon. Other than that, the
news is bad. It is nearly always fatal, it tends to strike people in
the prime of their lives, and the limited treatment options have
changed little over decades. It's no wonder then that many
researchers are determined to find new ways treat this poorly
understood type of cancer.

One approach focuses on a gene called STAT3. In several tumors, STAT3
takes the role of an oncogene, that is, a gene whose normal functions
are derailed and, as a result, becomes a driving force in a tumor's
development. Clearly then, blocking STAT3 would deal a major blow to
such tumors.

But a new study led by a team at Harvard Medical School has found
that STAT3 isn't always the villain. While it does behave as an
oncogene in certain types of glioblastoma, in others it becomes
what's called a "tumor suppressor gene," a type of gene often
responsible for keeping the renegade cancer cells in check.

In other words, the same gene in the same cancer can play a
completely different role from one person to the next, depending on
genetic nuances between individuals.

"This discovery lays the foundation for a more tailored therapeutic
intervention," says Azad Bonni, an associate professor of pathology
at Harvard Medical School, and senior author on this study. "And
that's really important. You can't just go blindly treating people by
inhibiting STAT3."

When most people think of brain cells, they think of neurons, those
cells whose electric signaling gives rise to our consciousness. But
another class of brain cells called astrocytes (named after their
uncanny resemblance to stars) actually outnumber neurons ten to one.
Despite their name, astrocytes play a less glitzy role than neurons
do. Typically, they're support cells, involved with functions such as
providing nutrients to nerve tissue and repairing scars. However,
nearly all brain cancers occur in astrocytes, or in the neural stem
cells that generate astrocytes.

Bonni, a neurologist and neuroscientist by training, decided to
investigate the genetic etiology of glioblastoma by studying whether
certain regulatory genes that control the generation of astrocytes
during normal development also play a role in these tumors. The logic
here is simple: since disease is often the breakdown of a normal
biological process, the more we understand how cells get it right,
the more we understand what can go wrong. And since STAT3 is a key
gene that turns neural stem cells into astrocytes during normal
development, what is its role in glioblastoma"

Bonni and two lead authors, N�ria de la Iglesia and Genevieve
Konopka, in collaboration with investigators in the laboratory of
Ronald DePinho at the Dana-Farber Cancer Institute, began by
genetically manipulating mouse astrocytes, then placing them into a
second group of mice whose immune systems had been compromised. The
findings surprised them.

Taking advantage of previously published data, the researchers looked
closely at how two genes, EGFR and PTEN--whose mutated forms are
associated with glioblastoma--affect the function of STAT3 in
astrocytes. Bonni's group found when EGFR is mutated, STAT3 is an
oncogene; with a PTEN mutation, STAT3 is a tumor suppressor.

"EGFR, in its normal state, is a transmembrane receptor, usually
performing its functions at the cell surface," says Bonni. "However,
when it's mutated, we find it in the cell's nucleus interacting with
STAT3--and turning it into an oncogene. STAT3 itself is not mutated
or damaged. It's the process of regulating STAT3 that gets damaged."

With PTEN, it's a completely different story. PTEN is itself a tumor
suppressor gene. When PTEN becomes disabled in astrocytes, these
potential tumors still have STAT3 standing in their way. This is
because STAT3 acts as a tumor suppressor normally in astrocytes.
However, as more PTEN becomes disabled, a cascade of molecular events
is set in motion with the express purpose of inhibiting STAT3
function and thus turning the tide in the cells toward tumor
formation.

The researchers confirmed these findings in human glioblastoma tumors
as well.

"The belief that STAT3 can only be an oncogene has been a pretty
entrenched dogma in the field," says Bonni, "so we performed many,
many experiments to make sure this was correct. It took some very
persistent investigators in my lab to get the job done. As a result,
we're convinced of our data."

While glioblastoma tends to be uncommon, STAT3 has also been
implicated in prostate and breast cancers, so these results may
translate to other types of tumors as well.

In addition, the findings contribute to the growing body of evidence
for "personalized medicine," showing that many types of cancers
contain subgroups that require different treatments.

This research was funded by the Stewart Trust of Washington, D.C.,
the Armenise-Harvard Foundation, and the Carolyn and Peter Lynch
Research Fund.

Journal citation: Genes and Development, Volume 22, Issue 4: February
15, 2008. "Identification of a PTEN-regulated STAT3 brain tumor
suppressor pathway" N�ria de la Iglesia, Genevieve Konopka, Sidharth
V. Puram, Jennifer A. Chan, Robert M. Bachoo, Mingjian J. You, David
E. Levy,Ronald A. DePinho, and Azad Bonni

Adapted from materials provided by Harvard Medical School, via
EurekAlert!, a service of AAAS.

http://www.topcancernews.com/news/1601/1/The-same-gene-in-the-same-
cancer-can-play-a-completely-different-role

__._,_.___
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:

Children's Neurobiological Solutions
http://www.CNSfoundation.org/

Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123

The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Recent Activity
Visit Your Group
Yahoo! News

Odd News

You won't believe

it, but it's true

Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

Yahoo! Groups

Find balance

between nutrition,

activity & well-being.

.

__,_._,___

No comments:



about stem cell research
adult stem cell
adult stem cell research
adult stem cells
against stem cell
against stem cell research
anti stem cell
anti stem cell research
autologous stem cell
autologous stem cell transplant
benefits of stem cell research
blood stem cells
bone marrow stem cells
bush stem cell
california stem cell
cancer stem cell
cancer stem cells
cell stem cell
cons of stem cell research
cord blood stem cell
cord blood stem cells
cord stem cells
diabetes stem cell
embryonic stem cell
embryonic stem cell research
embryonic stem cells
for stem cell research
funding for stem cell research
harvard stem cell
harvard stem cell institute
hematopoietic stem cell
hematopoietic stem cells
history of stem cell research
human embryonic stem cell
human embryonic stem cell research
human embryonic stem cells
international stem cell
mesenchymal stem cell
mesenchymal stem cells
neural stem cell
neural stem cells
nih stem cell
pluripotent stem cells
pro stem cell
pro stem cell research
pros and cons of stem cell
pros and cons of stem cell research
stem cell
stem cell bank
stem cell bill
stem cell biology
stem cell companies
stem cell conference
stem cell controversy
stem cell cures
stem cell debate
stem cell differentiation
stem cell ethics
stem cell funding
stem cell heart
stem cell information
stem cell institute
stem cell line
stem cell lines
stem cell news
stem cell policy
stem cell reasearch
stem cell reaserch
stem cell reseach
stem cell research
stem cell research articles
stem cell research bill
stem cell research controversy
stem cell research debate
stem cell research enhancement act
stem cell research ethics
stem cell research facts
stem cell research funding
stem cell research pros
stem cell research pros and cons
stem cell reserach
stem cell reserch
stem cell technologies
stem cell technology
stem cell therapy
stem cell transplant
stem cell transplantation
stem cell transplants
stem cell treatment
stem cell treatments
stem cell veto
stem cells
stem cells research
support stem cell research
types of stem cells
umbilical cord stem cells
what are stem cells
what is a stem cell
what is stem cell
what is stem cell research